Form 20-F ☒
|
Form 40-F ☐
|
Yes ☐
|
No ☒
|
·
|
Press release dated May 21, 2018 announcing results for the quarter ended March 31, 2018
|
·
|
First quarter earnings call presentation
|
o
|
Sales of $560.7 million, an increase of 19.8% from $468.2 million in Q4 2017
|
o
|
Net profit of $35.6 million, or $0.21 on a fully diluted per share basis, up from a net profit of $6.3 million, or $0.04 per share, in the prior quarter. Adjusted net profit of $33.3 million, or $0.19 on a fully diluted per share basis, compared to a net profit of $8.1 million, or $0.05 on a fully diluted per share basis, in the prior quarter
|
o
|
Reported EBITDA of $93.5 million, an increase of 321.2% compared to reported EBITDA of $22.2 million in Q4 2017
|
o
|
Adjusted EBITDA of $89.6 million, an increase of 66.9% compared to $53.7 million adjusted EBITDA in Q4 2017
|
o
|
The Board decided to reinstate the dividend with an interim payment of $0.06 per share with a record date of June 8, 2018 and a payment date of June 29, 2018
|
·
|
The average selling price for silicon metal increased by 13.2% to $2,762/MT in Q1 2018, as compared to $2,440/MT in Q4 2017;
|
·
|
The average selling price for silicon-based alloys increased by 12.3% to $1,956/MT in Q1 2018, as compared to $1,741/MT in Q4 2017; and
|
·
|
The average selling price for manganese-based alloys increased by 2.2% to $1,375/MT in Q1 2018, as compared to $1,346/MT in Q4 2017.
|
|
Quarter Ended
|
|
Quarter Ended
|
|
Quarter Ended
|
|
Year Ended
|
|||||
March 31, 2018
|
December 31, 2017
|
March 31, 2017
|
December 31, 2017
|
|||||||||
Shipments in metric tons:
|
||||||||||||
Silicon Metal
|
91,615
|
83,785
|
75,753
|
325,884
|
||||||||
Silicon-based Alloys
|
76,328
|
70,399
|
75,386
|
283,021
|
||||||||
Manganese-based Alloys
|
71,176
|
72,374
|
63,700
|
274,119
|
||||||||
Total shipments*
|
239,119
|
226,558
|
214,839
|
883,024
|
||||||||
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
Year Ended
|
|||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2017
|
|
December 31, 2017
|
|||||
Average selling price ($/MT):
|
||||||||||||
Silicon Metal
|
$
|
2,762
|
$
|
2,440
|
$
|
2,080
|
$
|
2,270
|
||||
Silicon-based Alloys
|
$
|
1,956
|
$
|
1,741
|
$
|
1,473
|
$
|
1,608
|
||||
Manganese-based Alloys
|
$
|
1,375
|
$
|
1,346
|
$
|
1,298
|
$
|
1,327
|
||||
Total*
|
$
|
2,092
|
$
|
1,873
|
$
|
1,635
|
$
|
1,765
|
||||
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
Year Ended
|
|||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2017
|
|
December 31, 2017
|
|||||
Average selling price ($/lb.):
|
||||||||||||
Silicon Metal
|
$
|
1.25
|
$
|
1.11
|
$
|
0.94
|
$
|
1.03
|
||||
Silicon-based Alloys
|
$
|
0.89
|
$
|
0.79
|
$
|
0.67
|
$
|
0.73
|
||||
Manganese-based Alloys
|
$
|
0.62
|
$
|
0.61
|
$
|
0.59
|
$
|
0.60
|
||||
Total*
|
$
|
0.95
|
$
|
0.85
|
$
|
0.74
|
$
|
0.80
|
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
Year Ended
|
|||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2017
|
|
December 31, 2017
|
|||||
Profit (loss) attributable to the parent
|
$
|
36,680
|
$
|
6,364
|
$
|
(6,554)
|
$
|
(678)
|
||||
Loss attributable to non-controlling interest
|
(1,066)
|
(84)
|
(1,561)
|
(5,144)
|
||||||||
Income tax (benefit) expense
|
15,668
|
(26,022)
|
(1,214)
|
(14,821)
|
||||||||
Net finance expense
|
13,156
|
19,659
|
12,970
|
61,704
|
||||||||
Financial derivatives loss
|
1,765
|
956
|
—
|
6,850
|
||||||||
Exchange differences
|
(729)
|
(2,500)
|
20
|
(8,214)
|
||||||||
Depreciation and amortization charges, operating allowances and write-downs
|
28,016
|
23,830
|
27,222
|
104,529
|
||||||||
EBITDA
|
93,490
|
22,203
|
30,883
|
144,226
|
||||||||
Non-controlling interest settlement
|
—
|
—
|
—
|
1,751
|
||||||||
Power credit
|
—
|
—
|
—
|
(3,696)
|
||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations
|
—
|
—
|
—
|
2,608
|
||||||||
Accrual of contingent liabilities
|
—
|
6,044
|
—
|
12,444
|
||||||||
Impairment loss
|
—
|
30,618
|
—
|
30,618
|
||||||||
Business interruption
|
—
|
—
|
—
|
(1,980)
|
||||||||
Revaluation of biological assets
|
—
|
(5,195)
|
—
|
(5,195)
|
||||||||
Step-up valuation adjustment
|
—
|
—
|
—
|
3,757
|
||||||||
Share-based compensation
|
(3,886)
|
—
|
—
|
—
|
||||||||
Adjusted EBITDA
|
$
|
89,604
|
$
|
53,670
|
$
|
30,883
|
$
|
184,533
|
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
Year Ended
|
|||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2017
|
|
December 31, 2017
|
|||||
Profit (loss) attributable to the parent
|
$
|
36,680
|
$
|
6,364
|
$
|
(6,554)
|
$
|
(678)
|
||||
Tax rate adjustment
|
(742)
|
(19,705)
|
1,771
|
(8,215)
|
||||||||
Non-controlling interest settlement
|
—
|
—
|
—
|
1,191
|
||||||||
Power credit
|
—
|
—
|
—
|
(2,513)
|
||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations
|
—
|
—
|
—
|
1,773
|
||||||||
Accrual of contingent liabilities
|
—
|
4,110
|
—
|
8,462
|
||||||||
Impairment loss
|
—
|
20,820
|
—
|
20,820
|
||||||||
Business interruption
|
—
|
—
|
—
|
(1,346)
|
||||||||
Revaluation of biological assets
|
—
|
(3,533)
|
—
|
(3,533)
|
||||||||
Step-up valuation adjustment
|
—
|
—
|
—
|
2,555
|
||||||||
Share-based compensation
|
(2,642)
|
—
|
—
|
—
|
||||||||
Adjusted profit (loss) attributable to the parent
|
$
|
33,296
|
$
|
8,056
|
$
|
(4,783)
|
$
|
18,516
|
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
Year Ended
|
|||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2017
|
|
December 31, 2017
|
|||||
Diluted profit (loss) per ordinary share
|
$
|
0.21
|
$
|
0.04
|
$
|
(0.04)
|
$
|
—
|
||||
Tax rate adjustment
|
—
|
(0.11)
|
0.01
|
(0.05)
|
||||||||
Non-controlling interest settlement
|
—
|
—
|
—
|
0.01
|
||||||||
Power credit
|
—
|
—
|
—
|
(0.01)
|
||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations
|
—
|
—
|
—
|
0.01
|
||||||||
Accrual of contingent liabilities
|
—
|
0.02
|
—
|
0.05
|
||||||||
Impairment loss
|
—
|
0.12
|
—
|
0.12
|
||||||||
Business interruption
|
—
|
—
|
—
|
(0.01)
|
||||||||
Revaluation of biological assets
|
—
|
(0.02)
|
—
|
(0.02)
|
||||||||
Step-up valuation adjustment
|
—
|
—
|
—
|
0.01
|
||||||||
Share-based compensation
|
(0.02)
|
—
|
—
|
—
|
||||||||
Adjusted diluted profit (loss) per ordinary share
|
$
|
0.19
|
$
|
0.05
|
$
|
(0.03)
|
$
|
0.11
|
|
Quarter Ended
March 31, 2018 |
|
Quarter Ended
December 31, 2017 |
|
Quarter Ended
March 31, 2017 |
|
Year Ended
December 31, 2017 |
|||||
Sales
|
|
$
|
560,704
|
$
|
468,218
|
$
|
396,037
|
$
|
1,741,693
|
|||
Cost of sales
|
|
(320,678)
|
(284,614)
|
(241,138)
|
(1,043,395)
|
|||||||
Other operating income
|
|
6,786
|
5,158
|
1,629
|
18,199
|
|||||||
Staff costs
|
|
(82,423)
|
(87,127)
|
(66,485)
|
(301,963)
|
|||||||
Other operating expense
|
|
(70,862)
|
(55,052)
|
(60,124)
|
(239,926)
|
|||||||
Depreciation and amortization charges, operating allowances and write-downs
|
|
(28,016)
|
(23,830)
|
(27,222)
|
(104,529)
|
|||||||
Impairment losses
|
—
|
(30,859)
|
—
|
(30,957)
|
||||||||
Other (loss) gain
|
(37)
|
6,479
|
964
|
575
|
||||||||
Operating profit (loss)
|
65,474
|
(1,627)
|
3,661
|
39,697
|
||||||||
Finance income
|
|
4,445
|
2,493
|
795
|
3,708
|
|||||||
Finance expense
|
|
(17,601)
|
(22,152)
|
(13,765)
|
(65,412)
|
|||||||
Financial derivatives loss
|
(1,765)
|
(956)
|
—
|
(6,850)
|
||||||||
Exchange differences
|
|
729
|
2,500
|
(20)
|
8,214
|
|||||||
Profit (loss) before tax
|
|
51,282
|
(19,742)
|
(9,329)
|
(20,643)
|
|||||||
Income tax (expense) benefit
|
|
(15,668)
|
26,022
|
1,214
|
14,821
|
|||||||
Profit (loss) for the period
|
35,614
|
6,280
|
(8,115)
|
(5,822)
|
||||||||
Loss attributable to non-controlling interest
|
|
1,066
|
84
|
1,561
|
5,144
|
|||||||
Profit (loss) attributable to the parent
|
|
$
|
36,680
|
$
|
6,364
|
$
|
(6,554)
|
$
|
(678)
|
|||
|
||||||||||||
EBITDA
|
$
|
93,490
|
$
|
22,203
|
$
|
30,883
|
$
|
144,226
|
||||
Adjusted EBITDA
|
$
|
89,604
|
$
|
53,670
|
$
|
30,883
|
$
|
184,533
|
||||
Weighted average shares outstanding
|
||||||||||||
Basic
|
171,977
|
171,953
|
171,838
|
171,949
|
||||||||
Diluted
|
172,215
|
172,128
|
171,838
|
171,949
|
||||||||
Profit (loss) per ordinary share
|
||||||||||||
Basic
|
$
|
0.21
|
$
|
0.04
|
$
|
(0.04)
|
$
|
—
|
||||
Diluted
|
$
|
0.21
|
$
|
0.04
|
$
|
(0.04)
|
$
|
—
|
March 31,
|
December 31,
|
March 31,
|
|||||||
|
2018
|
|
2017
|
|
2017
|
||||
ASSETS
|
|||||||||
Non-current assets
|
|||||||||
Goodwill
|
$
|
204,537
|
$
|
205,287
|
$
|
230,733
|
|||
Other intangible assets
|
61,774
|
58,658
|
56,854
|
||||||
Property, plant and equipment
|
980,101
|
917,974
|
790,501
|
||||||
Non-current financial assets
|
147,744
|
89,315
|
5,967
|
||||||
Deferred tax assets
|
6,581
|
5,273
|
47,768
|
||||||
Non-current receivables from related parties
|
2,464
|
2,400
|
2,139
|
||||||
Other non-current assets
|
32,125
|
30,059
|
20,892
|
||||||
Total non-current assets
|
1,435,326
|
1,308,966
|
1,154,854
|
||||||
Current assets
|
|||||||||
Inventories
|
493,108
|
361,231
|
312,757
|
||||||
Trade and other receivables
|
142,641
|
111,463
|
214,738
|
||||||
Current receivables from related parties
|
8,841
|
4,572
|
5,576
|
||||||
Current income tax assets
|
6,524
|
17,158
|
16,614
|
||||||
Current financial assets
|
897
|
2,469
|
3,640
|
||||||
Other current assets
|
16,095
|
9,926
|
10,703
|
||||||
Cash and cash equivalents
|
197,669
|
184,472
|
172,647
|
||||||
Assets and disposal groups classified as held for sale
|
—
|
—
|
120,094
|
||||||
Total current assets
|
865,775
|
691,291
|
856,769
|
||||||
Total assets
|
$
|
2,301,101
|
$
|
2,000,257
|
$
|
2,011,623
|
|||
EQUITY AND LIABILITIES
|
|||||||||
Equity
|
$
|
979,504
|
$
|
937,758
|
$
|
902,872
|
|||
Non-current liabilities
|
|||||||||
Deferred income
|
7,321
|
3,172
|
3,656
|
||||||
Provisions
|
82,957
|
82,397
|
83,993
|
||||||
Bank borrowings
|
71,242
|
—
|
78,123
|
||||||
Obligations under finance leases
|
68,101
|
69,713
|
1,906
|
||||||
Debt instruments
|
341,036
|
339,332
|
339,693
|
||||||
Other financial liabilities
|
58,288
|
49,011
|
86,962
|
||||||
Other non-current liabilities
|
64,457
|
3,536
|
2,317
|
||||||
Deferred tax liabilities
|
64,733
|
65,142
|
132,753
|
||||||
Total non-current liabilities
|
758,135
|
612,303
|
729,403
|
||||||
Current liabilities
|
|||||||||
Provisions
|
30,162
|
33,095
|
11,915
|
||||||
Bank borrowings
|
850
|
1,003
|
1,545
|
||||||
Obligations under finance leases
|
13,478
|
12,920
|
586
|
||||||
Debt instruments
|
2,735
|
10,938
|
4,156
|
||||||
Other financial liabilities
|
91,243
|
88,420
|
1,616
|
||||||
Payables to related parties
|
10,671
|
12,973
|
10,283
|
||||||
Trade and other payables
|
298,438
|
192,859
|
177,015
|
||||||
Current income tax liabilities
|
5,889
|
7,419
|
3,616
|
||||||
Other current liabilities
|
109,996
|
90,569
|
63,346
|
||||||
Liabilities associated with assets classified as held for sale
|
—
|
—
|
105,270
|
||||||
Total current liabilities
|
563,462
|
450,196
|
379,348
|
||||||
Total equity and liabilities
|
$
|
2,301,101
|
$
|
2,000,257
|
$
|
2,011,623
|
|
Quarter Ended March 31, 2018
|
Quarter Ended March 31, 2017
|
Year Ended
December 31, 2017 |
||||||
Cash flows from operating activities:
|
|||||||||
Profit (loss) for the period
|
$
|
35,614
|
$
|
(8,115)
|
$ |
(5,822)
|
|||
Adjustments to reconcile net profit (loss) to net cash (used) provided by operating activities:
|
|||||||||
Income tax expense (benefit)
|
15,668
|
(1,214)
|
(14,821)
|
||||||
Depreciation and amortization charges, operating allowances and write-downs
|
28,016
|
27,222
|
104,529
|
||||||
Finance income
|
(4,445)
|
(795)
|
(3,708)
|
||||||
Finance expense
|
17,601
|
13,765
|
65,412
|
||||||
Financial derivatives loss
|
1,765
|
—
|
6,850
|
||||||
Exchange differences
|
(729)
|
20
|
(8,214)
|
||||||
Impairment losses
|
—
|
—
|
30,957
|
||||||
(Gain) loss on disposals of non-current and financial assets
|
—
|
(558)
|
4,316
|
||||||
Share-based compensation
|
699
|
—
|
2,405
|
||||||
Other adjustments
|
37
|
(406)
|
(4,891)
|
||||||
Changes in operating assets and liabilities
|
|||||||||
(Increase) decrease in inventories
|
(107,481)
|
7,108
|
(16,274)
|
||||||
(Increase) decrease in trade receivables
|
(513)
|
3,765
|
50,168
|
||||||
Increase in trade payables
|
70,375
|
18,156
|
17,613
|
||||||
Other
|
(49,770)
|
(34,545)
|
(12,251)
|
||||||
Income taxes paid
|
(9,982)
|
(2,297)
|
(26,764)
|
||||||
Interest paid
|
(17,301)
|
(9,729)
|
(39,130)
|
||||||
Net cash (used) provided by operating activities
|
(20,446)
|
12,377
|
150,375
|
||||||
Cash flows from investing activities:
|
|||||||||
Payments due to investments:
|
|||||||||
Other intangible assets
|
(703)
|
(410)
|
(811)
|
||||||
Property, plant and equipment
|
(22,531)
|
(12,362)
|
(74,616)
|
||||||
Non-current financial assets
|
—
|
(14)
|
(343)
|
||||||
Disposals:
|
|||||||||
Non-current financial assets
|
942
|
—
|
—
|
||||||
Acquisition of subsidiary
|
(20,379)
|
—
|
—
|
||||||
Interest and finance income received
|
3,147
|
353
|
952
|
||||||
Net cash used by investing activities
|
(39,524)
|
(12,433)
|
(74,818)
|
||||||
Cash flows from financing activities:
|
|||||||||
Dividends paid
|
—
|
—
|
—
|
||||||
Payment for debt issuance costs
|
(4,476)
|
(10,477)
|
(16,765)
|
||||||
Proceeds from debt issuance
|
—
|
350,000
|
350,000
|
||||||
Increase/(decrease) in bank borrowings:
|
|||||||||
Borrowings
|
182,364
|
31,425
|
31,455
|
||||||
Payments
|
(106,514)
|
(372,380)
|
(453,948)
|
||||||
Proceeds from stock option exercises
|
—
|
—
|
180
|
||||||
Other amounts paid due to financing activities
|
(2,987)
|
(7,211)
|
(24,319)
|
||||||
Net cash provided (used) by financing activities
|
68,387
|
(8,643)
|
(113,397)
|
||||||
Total net cash flows for the period
|
8,417
|
(8,699)
|
(37,840)
|
||||||
Beginning balance of cash and cash equivalents
|
184,472
|
196,982
|
196,982
|
||||||
Exchange differences on cash and cash equivalents in foreign currencies
|
4,780
|
4,748
|
25,330
|
||||||
Ending balance of cash and cash equivalents
|
$
|
197,669
|
$ |
193,031
|
$ |
184,472
|
Date: May 21, 2018 | ||
|
FERROGLOBE PLC
|
|
|
|
|
|
by
|
/s/ Joseph Ragan
|
|
|
Name: Joseph Ragan
|
|
|
Title: Chief Financial Officer and Principal Accounting Officer (Principal Financial Officer)
|